Many states recognize BPS Board Certification in ways that support advanced pharmacy practice, including continuing education benefits, collaborative practice eligibility, and specialized practice authorization, as defined in state laws and regulations.
State Recognition by Category
The following states recognize BPS Board Certification through licensure requirements, pharmacy regulations, or specialized practice authorizations.
| State | Recognition Category | Source / Regulation |
|---|---|---|
| Alabama | Nuclear | Alabama ADC 680-X-2-.20 Nuclear Pharmacy |
| Arizona | Nuclear | Arizona ADC R4-23-681 General Requirements for Limited-service Nuclear Pharmacy |
| Arkansas | CE | Arkansas ADC 070-00-002.02-06 Continuing Education for Pharmacists |
| Arkansas | Nuclear | Arkansas ADC RH-8317 Training for Authorized Nuclear Pharmacist |
| California | CE | California ADC 16-1732.2 Board Accredited Continuing Education |
| California | Advanced Practice | Article 3.5. Advanced Practice Pharmacist |
| California | Other | California ADC 16-1730 Acceptable Certification Programs |
| California | Advanced Practice | California ADC 16-1730.1 Application Requirements for Advanced Practice Pharmacist Licensure. |
| California | Advanced Practice | CA Statute Bus and Prof 4210 Requirements for advanced practice pharmacist |
| Colorado | CPA | Colorado ADC 3-719-1-17.00.30 Pharmacist Qualifications [CPA] |
| Connecticut | CPA | Connecticut ADC 20-631-1 Competency Requirements [CPA] |
| Connecticut | Nuclear | Connecticut ADC 20-576-60 Definitions; Nuclear Pharmacy; Department; Testing |
| District of Columbia | CPA | District of Columbia ADC 17-10001 Requirements for participation in a collaborative practice agreement |
| Georgia | Nuclear | Georgia ADC 480-25-.03 Licensure of Nuclear Pharmacists |
| Maine | CPA | ME Statute 32-13842 Qualifications [CPA] |
| Maryland | CPA | COMAR 10.34.29.04, Requirements for Participation in Drug Therapy Management |
| Massachusetts | CPA | MA Subreg 2019-02-07: Board of Registration in Pharmacy Advisory: Educational Equivalency for Collaborative Drug Therapy Management (CDTM) Agreements |
| Michigan | CE | Michigan ADC R338.3044 Acceptable continuing education for licensees |
| Michigan | Sterile Compounding | Michigan ADC R338.533 Compounding standards and requirements; outsourcing facilities; requirements |
| Minnesota | Nuclear | Minnesota ADC 6800.8500 Pharmacist-In-Charge - Radioactive Drugs [Nuclear] |
| Mississippi | Nuclear | Mississippi ADC 30-030-3001, Article XXVII Nuclear/radiologic pharmacy |
| Missouri | Nuclear | Missouri ADC 20-2220-2.500 Nuclear Pharmacy—Minimum Standards for Operation |
| Montana | Advanced Practice | MT ADC 24.174.526: Clinical pharmacist practitioner qualifications and requirements |
| Nebraska | CE | Nebraska ADC 172-128-005 Continuing competency [CE] |
| Nebraska | Credentialing/Reciprocity | Nebraska ADC 172-128-003 Credentialing requirements [Reciprocity] |
| Nevada | Nuclear | Nevada ADC 639.5818 Nuclear pharmacist: Certification; training and instruction; affidavit of experience and training |
| New Hampshire | Nuclear | New Hampshire ADC Ph 405.03 General Requirements for Pharmacies Providing Radiopharmaceutical Services [Nuclear] |
| New Jersey | CPA | N.J.A.C. 13:39-13.3 Board approval; pharmacist qualifications; continuing education |
| New Jersey | Nuclear | New Jersey ADC 13:39-12.3 General requirements for a nuclear pharmacist |
| New Mexico | Nuclear | New Mexico ADC 16.19.18.7 Definitions [Nuclear] |
| New York | Nuclear | NY State Board of Pharmacy 2023-02-06 Nuclear Pharmacist Certification: Information |
| North Carolina | Nuclear | North Carolina ADC 21-46.2702 Definitions [Nuclear] |
| North Dakota | Nuclear | North Dakota ADC 61-05-01-04 General requirements for nuclear pharmacists to manage a nuclear pharmacy providing radiopharmaceutical services |
| Ohio | CE | Ohio ADC 4729:1-5-02 Continuing education requirements for pharmacists |
| Ohio | CE | Ohio ADC 4729:1-5-01 Pharmacist continuing education – definitions |
| Ohio | CE | OH Board of Pharmacy 2024-12-11 Pharmacist CE: Pharmacist Continuing Education (CE) Reporting Requirements |
| Ohio | CPA | Ohio ADC 4729:1-6-02 Consult agreements |
| Ohio | Nuclear | Ohio ADC 3701:1-58-20 Training for an authorized nuclear pharmacist. |
| Oklahoma | Nuclear | Oklahoma ADC 535:15-17-3 Definitions [Nuclear] |
| Oregon | Nuclear | Oregon ADC 855-115-0070 Notification: Nuclear Pharmacists |
| Rhode Island | CPA | RI Statute 5-19.2-2 Definitions [CPA] |
| Rhode Island | Nuclear | Rhode Island ADC 216-40-15-1.2 Definitions [Nuclear] |
| South Carolina | Nuclear | SC Statute 40-43-87 Nuclear/radiologic pharmacy practice; regulations set by Nuclear Regulatory Commission; revocation of materials license; inspections; hearings regarding violations of state or federal law; space and equipment requirements |
| Texas | CE | Texas ADC 22-295.8 Continuing Education Requirements [CE] |
| Texas | Other | Texas ADC 22-295.12 Pharmacist Certification Programs |
| Texas | Other | Texas State Board of Pharmacy Pharmacist Certification Update Form |
| Texas | Nuclear | Texas ADC 22-291.53 Personnel (Class B/ Nuclear Pharmacies) [Nuclear] |
| Utah | CE | Utah ADC R156-17b-309 Continuing Education |
| Vermont | Nuclear | Vermont ADC 04-030-230.15.2 Definitions [Nuclear] |
| West Virginia | CPA | West Virginia ADC 11-8-3 Requirements for Collaborative Pharmacy Practice |
| West Virginia | CPA | WV Statute 30-5-18 Pharmacist requirements to participate in a collaborative pharmacy practice agreement |
| Wisconsin | Nuclear | Wisconsin ADC 157.61(9) Training for an authorized nuclear pharmacist |
| Wyoming | Sterile Compounding | Wyoming ADC 059.0001.8 § 7(d) Outsourcing Facilities – Pharmacist Training/Certification Requirements |
Last updated: October 2025
State regulations change periodically. Information is based on publicly available sources and may be updated as regulations evolve. The Board of Pharmacy Specialties (BPS) is not a primary source for state regulatory requirements. Pharmacists should consult their state board of pharmacy or licensing authority for the most current and official information.